COSCIENS Biopharma Inc. Cost Of Inventories Recognised As Expense During Period
COSCIENS Biopharma Inc. (CSCIF) reported Cost Of Inventories Recognised As Expense During Period of $2.09 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Expense Statement
ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod · last filed 2019-04-01
| Period end | Cost Of Inventories Recognised As Expense During Period 12 month |
|---|---|
| 2018-12-31 | $2.09M 20-F · filed 2019-04-01 |
| 2017-12-31 | $0.00 20-F · filed 2019-04-01 |